Richard young 2023

Richard Young

Managing Director and Principal Toxicologist

Qualifications

BSc in Marine Biology & Coastal Ecology

MSc in Applied Toxicology

UK Registered Toxicologist (UKRT)

European Registered Toxicologist (ERT)

Richard Young,
Managing Director and Principal Toxicologist

Richard has over 20 years’ experience in desk-based toxicology at bibra. In 2018, Richard became the Managing Director of bibra. 

Richard has worked for clients from the food and beverage, food contact materials, consumer goods, agrochemical, biocidal, industrial chemical, pharmaceutical, electronic cigarette and cannabinoid sectors. For the past 15 years, he has been heavily involved in assisting companies comply with their REACH registration obligations, including supporting registrants respond to ECHA Evaluation decisions. 

Richard has played a key role in assisting e-cigarette and e-liquid manufacturers and importers with the toxicological assessments of their products, notably with their EU TPD and US FDA PMTA compliance obligations. Most recently he has been involved in the toxicological assessment of cannabinoids (notably CBD and THC) for a number of clients from a range of sectors (e.g. food, consumer products and pharmaceuticals). 

Qualifications & Experience 

Richard has an MSc in Applied Toxicology and is a RSB/BTS and European Registered Toxicologist (ERT)

His skills include expert analysis of human health data. This can involve the pragmatic application of risk assessment methodology to mammalian toxicity data sets in order to derive robust conclusions on toxicological acceptability and health risks to exposed populations. In 2018, Richard became the Managing Director of bibra. 

Areas of Expertise 

Hobbies & Interests 

In his spare time Richard can be found playing padel tennis and 5-a-side football (when his knees can cope), and running around and entertaining his two children.

Richard's case studies and blog posts

Health risk assessments relating to the excipient components of the Voke® formulation

Case study

A novel nicotine replacement device was designed to deliver a pressurised nicotine formulation via a breath operated valve in a cigarette sized medical device. Kind Consumer received a Marketing Authorisation for its lead product, Voke®, in September 2014.

Cannabinoids – preparation of several inhalation focused toxicity profiles

Case study

The client requested the production of a series of urgent toxicity profiles for more than a dozen different cannabinoids, to support and inform their Research & Development (R&D) of new inhalable (non nicotine) consumer products (including their possible incorporation as ingredients into e liquids).

Updating REACH dossiers following ECHA Evaluation decisions

Case study

Manufacturers of chemicals in, or importers into, the European Union are required under the REACH regulation to submit a dossier of information on their substances to the European Chemicals Agency (ECHA). The Agency can, after evaluating the information provided by the registrant, require the company to update or amend their dossier, including with the addition of new experimental data. This is called a “Compliance Check decision”

Want to read more case studies and blog posts that Richard has been involved in? Click below to read more.

Contact us